Functionally, PD-1 expressed on activated T lymphocytes engages PD-L1 expressed by malignant cells or stromal antigen-presenting cells, initiating inhibitory signaling cascades that attenuate T cell effector functions while establishing immune privileged niches for tumor progression [32]. Here, PDCD1 is linked to neoplasm.